News
IRMD
43.40
+0.07%
0.03
Weekly Report: what happened at IRMD last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at IRMD last week (0311-0315)?
Weekly Report · 03/18 10:57
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live fireside chat on Tuesday, March 19, at 12:30 p.m. PT.
Barchart · 03/13 15:30
Weekly Report: what happened at IRMD last week (0304-0308)?
Weekly Report · 03/11 10:54
Weekly Report: what happened at IRMD last week (0226-0301)?
Weekly Report · 03/04 10:57
Weekly Report: what happened at IRMD last week (0219-0223)?
Weekly Report · 02/26 11:08
Weekly Report: what happened at IRMD last week (0212-0216)?
Weekly Report · 02/19 11:10
Weekly Report: what happened at IRMD last week (0205-0209)?
Weekly Report · 02/12 11:00
IRadimed Corp reports results for the quarter ended in December - Earnings Summary
IRadimed Corp reports quarterly adjusted earnings of 39 cents per share for the quarter ended in December. Revenue rose 17.4% to $17.45 million from a year ago. The company reported quarterly income of $4.54 million. Wall Street expected earnings of 40 cents.
Reuters · 02/08 17:43
iRadimed Q4 Adjusted EPS $0.39 Misses $0.40 Estimate, Sales $17.45M Beat $17.33M Estimate
IRadimed reported quarterly earnings of $0.39 per share. The company reported quarterly sales of $17.45 million. This is a 17.42 percent increase over sales of the same period last year. The firm missed the analyst consensus estimate by 2.5 percent.
Benzinga · 02/08 13:06
BRIEF-IRadimed Q4 EPS USD 0.36
Reuters · 02/08 13:05
Press Release: IRADIMED CORPORATION Announces -3-
Outstanding: The company reported a net loss for the three months ended December 31, 2017. Total revenue for the quarter was $9.1 billion. The Company's diluted net income per share was $1.10 billion. The company's diluted earnings per share for the year was $2.02 billion.
Dow Jones · 02/08 13:05
Press Release: IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
Iradimed Corp. Reports record revenue of $17.5 million for the fourth quarter and $65.6 million in the full year of 2023. The Company is a leader in the development of innovative magnetic resonance imaging medical devices. The company is the only provider of a non-magnetic IV infusion pump system.
Dow Jones · 02/08 13:05
iRadimed's Earnings Outlook
IRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Thursday. Analysts estimate the company will report an earnings per share of $0.40. Last quarter the company beat its earnings estimate but the share price dropped by 0.0%. Shares are up 27.7% over the last 52 weeks.
Benzinga · 02/07 18:02
iRadimed Q4 2023 Earnings Preview
Seeking Alpha · 02/07 15:48
Lake Street Reaffirms Their Buy Rating on Iradimed (IRMD)
TipRanks · 02/05 13:55
Weekly Report: what happened at IRMD last week (0129-0202)?
Weekly Report · 02/05 11:07
IRadimed: Caution On The Valuation Of This Excellent Company
Seeking Alpha · 02/01 05:44
Weekly Report: what happened at IRMD last week (0122-0126)?
Weekly Report · 01/29 10:58
Weekly Report: what happened at IRMD last week (0115-0119)?
Weekly Report · 01/22 11:01
More
Webull provides a variety of real-time IRMD stock news. You can receive the latest news about Iradimed Corp through multiple platforms. This information may help you make smarter investment decisions.
About IRMD
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.